A study by Abele et al. [10] assessed the Mindpeak Breast Ki-67 RoI and Mindpeak ER/PR RoI for quantifying Ki-67, ER, and progesterone receptor PR in breast cancer. This evidence concerns the gene ESR1 and breast carcinoma.